Selected research
Market Outlook & Growth Opportunities
Global Biktarvy Market Outlook and Growth Opportunities 2026
Market perspective
The global Biktarvy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biktarvy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biktarvy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biktarvy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biktarvy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biktarvy market include Hetero Drugs, Gilead Sciences, Medcorp Technologies, Gador SA, BMODESTO and ABACUS MEDICINE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biktarvy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biktarvy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biktarvy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biktarvy market size, projected growth trends, production technologies, key applications, and end-use industries.
Biktarvy Segment by Company
Hetero Drugs
Gilead Sciences
Medcorp Technologies
Gador SA
BMODESTO
ABACUS MEDICINE
Biktarvy Segment by Type
Brands Drug
Generic Drugs
Biktarvy Segment by Application
Hospitals
Retail Pharmacy
Others
Biktarvy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biktarvy status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Biktarvy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biktarvy significant trends, drivers, influence factors in global and regions.
6. To analyze Biktarvy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biktarvy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biktarvy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biktarvy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biktarvy market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biktarvy industry.
Chapter 3: Detailed analysis of Biktarvy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Biktarvy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Biktarvy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Brands Drug
- Generic Drugs
Applications
- Hospitals
- Retail Pharmacy
- Others
Companies covered
- Hetero Drugs
- Gilead Sciences
- Medcorp Technologies
- Gador SA
- BMODESTO
- ABACUS MEDICINE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biktarvy Sales Value (2021-2032)
- 1.2.2 Global Biktarvy Sales Volume (2021-2032)
- 1.2.3 Global Biktarvy Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Biktarvy Market Dynamics
- 2.1 Biktarvy Industry Trends
- 2.2 Biktarvy Industry Drivers
- 2.3 Biktarvy Industry Opportunities and Challenges
- 2.4 Biktarvy Industry Restraints
3 Biktarvy Market by Company
- 3.1 Global Biktarvy Company Revenue Ranking in 2025
- 3.2 Global Biktarvy Revenue by Company (2021-2026)
- 3.3 Global Biktarvy Sales Volume by Company (2021-2026)
- 3.4 Global Biktarvy Average Price by Company (2021-2026)
- 3.5 Global Biktarvy Company Ranking (2024-2026)
- 3.6 Global Biktarvy Company Manufacturing Base and Headquarters
- 3.7 Global Biktarvy Company Product Type and Application
- 3.8 Global Biktarvy Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Biktarvy Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Biktarvy Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Biktarvy Market by Type
- 4.1 Biktarvy Type Introduction
- 4.1.1 Brands Drug
- 4.1.2 Generic Drugs
- 4.2 Global Biktarvy Sales Volume by Type
- 4.2.1 Global Biktarvy Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biktarvy Sales Volume by Type (2021-2032)
- 4.2.3 Global Biktarvy Sales Volume Share by Type (2021-2032)
- 4.3 Global Biktarvy Sales Value by Type
- 4.3.1 Global Biktarvy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biktarvy Sales Value by Type (2021-2032)
- 4.3.3 Global Biktarvy Sales Value Share by Type (2021-2032)
5 Biktarvy Market by Application
- 5.1 Biktarvy Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Biktarvy Sales Volume by Application
- 5.2.1 Global Biktarvy Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biktarvy Sales Volume by Application (2021-2032)
- 5.2.3 Global Biktarvy Sales Volume Share by Application (2021-2032)
- 5.3 Global Biktarvy Sales Value by Application
- 5.3.1 Global Biktarvy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biktarvy Sales Value by Application (2021-2032)
- 5.3.3 Global Biktarvy Sales Value Share by Application (2021-2032)
6 Biktarvy Regional Sales and Value Analysis
- 6.1 Global Biktarvy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biktarvy Sales by Region (2021-2032)
- 6.2.1 Global Biktarvy Sales by Region: 2021-2026
- 6.2.2 Global Biktarvy Sales by Region (2027-2032)
- 6.3 Global Biktarvy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Biktarvy Sales Value by Region (2021-2032)
- 6.4.1 Global Biktarvy Sales Value by Region: 2021-2026
- 6.4.2 Global Biktarvy Sales Value by Region (2027-2032)
- 6.5 Global Biktarvy Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Biktarvy Sales Value (2021-2032)
- 6.6.2 North America Biktarvy Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Biktarvy Sales Value (2021-2032)
- 6.7.2 Europe Biktarvy Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Biktarvy Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Biktarvy Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Biktarvy Sales Value (2021-2032)
- 6.9.2 South America Biktarvy Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Biktarvy Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Biktarvy Sales Value Share by Country, 2025 VS 2032
7 Biktarvy Country-level Sales and Value Analysis
- 7.1 Global Biktarvy Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biktarvy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Biktarvy Sales by Country (2021-2032)
- 7.3.1 Global Biktarvy Sales by Country (2021-2026)
- 7.3.2 Global Biktarvy Sales by Country (2027-2032)
- 7.4 Global Biktarvy Sales Value by Country (2021-2032)
- 7.4.1 Global Biktarvy Sales Value by Country (2021-2026)
- 7.4.2 Global Biktarvy Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Biktarvy Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Biktarvy Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Biktarvy Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Biktarvy Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Biktarvy Sales Value Growth Rate (2021-2032)
- 7.9.2 France Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Biktarvy Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Biktarvy Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Biktarvy Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Biktarvy Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Biktarvy Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Biktarvy Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Biktarvy Sales Value Growth Rate (2021-2032)
- 7.16.2 China Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Biktarvy Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Biktarvy Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Biktarvy Sales Value Growth Rate (2021-2032)
- 7.19.2 India Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Biktarvy Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Biktarvy Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Biktarvy Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Biktarvy Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Biktarvy Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Biktarvy Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Biktarvy Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Biktarvy Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Biktarvy Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Biktarvy Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Biktarvy Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Biktarvy Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Biktarvy Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Biktarvy Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Biktarvy Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Biktarvy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Hetero Drugs
- 8.1.1 Hetero Drugs Company Information
- 8.1.2 Hetero Drugs Business Overview
- 8.1.3 Hetero Drugs Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Hetero Drugs Biktarvy Product Portfolio
- 8.1.5 Hetero Drugs Recent Developments
- 8.2 Gilead Sciences
- 8.2.1 Gilead Sciences Company Information
- 8.2.2 Gilead Sciences Business Overview
- 8.2.3 Gilead Sciences Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Gilead Sciences Biktarvy Product Portfolio
- 8.2.5 Gilead Sciences Recent Developments
- 8.3 Medcorp Technologies
- 8.3.1 Medcorp Technologies Company Information
- 8.3.2 Medcorp Technologies Business Overview
- 8.3.3 Medcorp Technologies Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Medcorp Technologies Biktarvy Product Portfolio
- 8.3.5 Medcorp Technologies Recent Developments
- 8.4 Gador SA
- 8.4.1 Gador SA Company Information
- 8.4.2 Gador SA Business Overview
- 8.4.3 Gador SA Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Gador SA Biktarvy Product Portfolio
- 8.4.5 Gador SA Recent Developments
- 8.5 BMODESTO
- 8.5.1 BMODESTO Company Information
- 8.5.2 BMODESTO Business Overview
- 8.5.3 BMODESTO Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.5.4 BMODESTO Biktarvy Product Portfolio
- 8.5.5 BMODESTO Recent Developments
- 8.6 ABACUS MEDICINE
- 8.6.1 ABACUS MEDICINE Company Information
- 8.6.2 ABACUS MEDICINE Business Overview
- 8.6.3 ABACUS MEDICINE Biktarvy Sales, Value and Gross Margin (2021-2026)
- 8.6.4 ABACUS MEDICINE Biktarvy Product Portfolio
- 8.6.5 ABACUS MEDICINE Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biktarvy Value Chain Analysis
- 9.1.1 Biktarvy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biktarvy Sales Mode & Process
- 9.2 Biktarvy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biktarvy Distributors
- 9.2.3 Biktarvy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst